Patent Protection And Transfer Of Technology In Biotechnology | 17136
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Patent protection and transfer of technology in biotechnology

5th World Congress on Biotechnology

Maria Rosa De La Colina Montero

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.S1.027

Biotechnology is a leading field of research. Society, however, does not take advantage of the many findings linked to Biotechnology because the findings are published before any action has been taken to transfer the associated knowledge and technology to those companies that can develop a commercial product and put it on the market. A suitable transfer of technology requires a solid support base for Technology Transfer Departments and a fluid relationship with their researchers. Patents, inter alia, can be one way to enhance the value of the technology to be transferred. Researchers should be aware of the possible benefits that technology transfers can mean for their groups. To prevent early disclosures, which would prevent further protection of IP rights, scientists should become familiar with the concepts of novelty, inventive step and sufficiency of description. This scenario could help to achieve strong patents, substantial revenue, a profitable transfer of technology and harmonisation of publication, and protection of inventions. A good knowledge of the special requirements for Biotechnology protection may help to avoid irreversible errors and to save money during the patent prosecution process. Proper advice is therefore recommended.
Maria Rosa De La Colina Monteroholds an MSc in chemistry with specialized studies in biochemistry and molecular biology and a second MSc in Food Science and Technology. A European Patent Attorney since 2010, Rosa began her professional career as a biomedical researcher and has been a patent practitioner defending innovation since 2004. Her main areas of expertise are biotechnology, food technology, and pharmaceuticals, advising companies and research centers in patent drafting and prosecution, technology transfer and freedom to operate. She is active in advising and training scientists at research centers in industrial property matters and teaches in several degree programmes.